Equities

Certara Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Certara Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)7.05
  • Today's Change-0.03 / -0.42%
  • Shares traded4.06m
  • 1 Year change-41.15%
  • Beta1.5048
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,400 biopharmaceutical companies, academic institutions and regulatory agencies across 70 countries.

  • Revenue in USD (TTM)418.84m
  • Net income in USD-1.60m
  • Incorporated2017
  • Employees1.52k
  • Location
    Certara Inc4 Radnor Corporate Center, Suite 350RADNOR 19087United StatesUSA
  • Phone+1 (415) 237-8272
  • Fax+1 (302) 636-5454
  • Websitehttps://www.certara.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Newegg Commerce Inc1.31bn-22.56m932.17m762.00--7.60--0.7099-1.14-1.1467.715.853.508.1840.071,723,264.00-6.01-6.75-13.05-16.0411.2812.32-1.72-1.860.5156--0.1215---17.46403.0726.55------
Amplitude Inc343.21m-88.54m976.20m780.00--3.99--2.84-0.6715-0.67152.601.830.7921--13.79440,016.70-20.43-22.17-31.77-31.4173.9972.79-25.80-33.35----0.00--14.6827.356.13--10.50--
Liquidity Services Inc475.56m29.77m980.35m818.0034.444.5224.362.060.91790.917914.666.991.3518.4625.33581,365.508.4810.9414.0619.1145.3551.816.269.481.43--0.000.0031.2018.2840.53--12.92--
Hello Group Inc (ADR)1.52bn109.93m1.02bn1.39k10.47--8.960.66830.6180.6188.62--0.6539--47.911,093,925.004.433.945.964.8337.0942.576.785.70----0.0006122.36-11.99-9.09-46.90-18.948.89--
Ziff Davis Inc1.45bn47.35m1.02bn3.90k25.070.59263.590.70261.081.0834.7245.690.394--2.19372,120.001.503.292.054.0085.7685.943.818.49--9.600.33070.003.544.60-24.8910.664.50--
Porch Group Inc482.41m-3.36m1.02bn799.00----25.732.12-0.038-0.0384.53-0.19840.5988--31.72603,772.201.90-9.572.83-16.5570.4857.443.18-22.79--2.080.9461--10.1846.1789.76--37.90--
REalloys Inc2.43m-4.43m1.05bn10.00--14.07--433.64-1.15-1.150.64051.310.2618365.64177.66243,124.00-47.65-50.33-77.40-76.4847.9656.71-182.05-105.330.0231-10.130.0836---5.29-6.31-27.51------
Coursera Inc757.50m-51.00m1.08bn1.31k--1.69--1.42-0.3089-0.30894.623.790.7849--12.11579,571.60-5.28-12.71-8.19-18.0754.5756.01-6.73-18.75----0.00--9.0420.8835.87--20.44--
C3.ai Inc307.39m-434.50m1.12bn1.18k--1.56--3.64-3.16-3.162.245.110.3151--2.02260,280.30-44.54-20.97-51.30-23.8243.4565.79-141.35-77.37--------25.2719.95-3.22--1.09--
Certara Inc418.84m-1.60m1.13bn1.52k--1.0615.322.69-0.0103-0.01032.616.680.2675--4.08276,460.70-0.1019-0.8845-0.1126-0.95861.5360.63-0.3808-3.79--2.250.2162--8.7511.4586.76--27.32--
LegalZoom.com Inc756.04m15.43m1.22bn1.20k83.487.2620.411.610.08420.08424.140.96771.71--51.96632,143.003.48-4.8110.24-12.6965.8865.462.04-2.98----0.00001--10.889.94-48.5116.3923.39--
Akso Health Group - ADR14.78m-134.98m1.23bn27.00------83.12-0.4011-0.40110.0518--0.082878.9630.97547,325.90-75.90-41.04-79.81-53.35-1.914.71-916.71-456.5514.18-196,149.000.0099--512.0816.40-1,389.98---5.07--
Youdao Inc - ADR861.64m15.65m1.28bn3.75k82.27----1.490.13030.13037.22-2.413.1220.8714.77--5.12-19.63----44.2948.971.64-7.870.53893.71----5.0318.5230.57------
Data as of Mar 02 2026. Currency figures normalised to Certara Inc's reporting currency: US Dollar USD

Institutional shareholders

48.15%Per cent of shares held by top holders
HolderShares% Held
Wasatch Advisors LPas of 31 Dec 202517.22m10.81%
BlackRock Fund Advisorsas of 31 Dec 202512.98m8.15%
The Vanguard Group, Inc.as of 31 Dec 202511.02m6.92%
Dimensional Fund Advisors LPas of 31 Dec 20258.10m5.08%
Teacher Retirement System of Texasas of 31 Dec 20255.60m3.52%
ArrowMark Colorado Holdings LLCas of 31 Dec 20255.49m3.44%
Geneva Capital Management LLCas of 31 Dec 20255.41m3.40%
SSgA Funds Management, Inc.as of 31 Dec 20253.92m2.46%
Brown Brothers Harriman & Co. (Investment Management)as of 31 Dec 20253.76m2.36%
Citadel Advisors LLCas of 31 Dec 20253.19m2.00%
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.